United Polyfab Gujarat Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:47 am

Competitors of United Polyfab Gujarat Ltd

All Competitor Stocks of United Polyfab Gujarat Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:45 am

Below is a detailed analysis of the quarterly data for United Polyfab Gujarat Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 146.18 Cr.. The value appears to be declining and may need further review. It has decreased from 153.43 Cr. (Mar 2025) to 146.18 Cr., marking a decrease of 7.25 Cr..
• For Expenses, as of Jun 2025, the value is 132.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 142.26 Cr. (Mar 2025) to 132.82 Cr., marking a decrease of 9.44 Cr..
• For Operating Profit, as of Jun 2025, the value is 13.36 Cr.. The value appears strong and on an upward trend. It has increased from 11.17 Cr. (Mar 2025) to 13.36 Cr., marking an increase of 2.19 Cr..
• For OPM %, as of Jun 2025, the value is 9.14%. The value appears strong and on an upward trend. It has increased from 7.28% (Mar 2025) to 9.14%, marking an increase of 1.86%.
• For Other Income, as of Jun 2025, the value is 0.43 Cr.. The value appears strong and on an upward trend. It has increased from 0.28 Cr. (Mar 2025) to 0.43 Cr., marking an increase of 0.15 Cr..
• For Interest, as of Jun 2025, the value is 2.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.71 Cr. (Mar 2025) to 2.40 Cr., marking a decrease of 0.31 Cr..
• For Depreciation, as of Jun 2025, the value is 3.40 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.40 Cr..
• For Profit before tax, as of Jun 2025, the value is 7.99 Cr.. The value appears strong and on an upward trend. It has increased from 5.34 Cr. (Mar 2025) to 7.99 Cr., marking an increase of 2.65 Cr..
• For Tax %, as of Jun 2025, the value is 25.78%. The value appears to be improving (decreasing) as expected. It has decreased from 26.78% (Mar 2025) to 25.78%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 5.93 Cr.. The value appears strong and on an upward trend. It has increased from 3.90 Cr. (Mar 2025) to 5.93 Cr., marking an increase of 2.03 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.26. The value appears strong and on an upward trend. It has increased from 0.17 (Mar 2025) to 0.26, marking an increase of 0.09.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:13 am

Growth

Last Updated: September 5, 2025, 1:50 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for United Polyfab Gujarat Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 3.09 (Mar 24) to 7.71, marking an increase of 4.62.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 3.09 (Mar 24) to 7.71, marking an increase of 4.62.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.37. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 13.37, marking an increase of 4.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.40. It has increased from 34.70 (Mar 24) to 42.40, marking an increase of 7.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.40. It has increased from 34.70 (Mar 24) to 42.40, marking an increase of 7.70.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 262.38. It has decreased from 395.82 (Mar 24) to 262.38, marking a decrease of 133.44.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 19.13. This value is within the healthy range. It has increased from 14.88 (Mar 24) to 19.13, marking an increase of 4.25.
• For PBIT / Share (Rs.), as of Mar 25, the value is 13.47. This value is within the healthy range. It has increased from 9.30 (Mar 24) to 13.47, marking an increase of 4.17.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.26. This value is within the healthy range. It has increased from 5.36 (Mar 24) to 9.26, marking an increase of 3.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 2.88 (Mar 24) to 7.71, marking an increase of 4.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 2.88 (Mar 24) to 7.71, marking an increase of 4.83.
• For PBDIT Margin (%), as of Mar 25, the value is 7.29. This value is below the healthy minimum of 10. It has increased from 3.75 (Mar 24) to 7.29, marking an increase of 3.54.
• For PBIT Margin (%), as of Mar 25, the value is 5.13. This value is below the healthy minimum of 10. It has increased from 2.34 (Mar 24) to 5.13, marking an increase of 2.79.
• For PBT Margin (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 10. It has increased from 1.35 (Mar 24) to 3.52, marking an increase of 2.17.
• For Net Profit Margin (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 5. It has increased from 0.72 (Mar 24) to 2.93, marking an increase of 2.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 8. It has increased from 0.72 (Mar 24) to 2.93, marking an increase of 2.21.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.17. This value is within the healthy range. It has increased from 8.29 (Mar 24) to 18.17, marking an increase of 9.88.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.16. This value is within the healthy range. It has increased from 13.45 (Mar 24) to 20.16, marking an increase of 6.71.
• For Return On Assets (%), as of Mar 25, the value is 7.18. This value is within the healthy range. It has increased from 2.72 (Mar 24) to 7.18, marking an increase of 4.46.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.50. This value is within the healthy range. It has decreased from 0.88 (Mar 24) to 0.50, marking a decrease of 0.38.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.58 (Mar 24) to 1.22, marking a decrease of 0.36.
• For Current Ratio (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.63, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.15, marking a decrease of 0.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.54. This value is within the healthy range. It has increased from 3.78 (Mar 24) to 4.54, marking an increase of 0.76.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 3. It has increased from 1.73 (Mar 24) to 2.83, marking an increase of 1.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 456.59. It has increased from 330.67 (Mar 24) to 456.59, marking an increase of 125.92.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 24) to 0.75, marking an increase of 0.39.
• For EV / EBITDA (X), as of Mar 25, the value is 10.40. This value is within the healthy range. It has increased from 9.68 (Mar 24) to 10.40, marking an increase of 0.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.56, marking an increase of 0.33.
• For Price / BV (X), as of Mar 25, the value is 3.53. This value exceeds the healthy maximum of 3. It has increased from 2.64 (Mar 24) to 3.53, marking an increase of 0.89.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.56, marking an increase of 0.33.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness